18 results
20-F
2016 FY
EX-4.19
BYSI
BeyondSpring Inc
28 Apr 17
Annual report (foreign)
12:00am
C.F.R. § 312.21(b) in the United States, or an equivalent or counterpart of the foregoing in the European Union.
“Phase 3 Trial” means the third phase … of 21 C.F.R. § 312.21(c) in the United States, or an equivalent or counterpart of the foregoing in the European Union.
BeyondSpring Inc.
28 Liberty
20-F
2016 FY
EX-4.18
BYSI
BeyondSpring Inc
28 Apr 17
Annual report (foreign)
12:00am
C.F.R. § 312.21(b) in the United States, or an equivalent or counterpart of the foregoing in the European Union.
“Phase 3 Trial” means the third phase … of 21 C.F.R. § 312.21(c) in the United States, or an equivalent or counterpart of the foregoing in the European Union.
BeyondSpring Inc.
28 Liberty
20-F
2016 FY
BYSI
BeyondSpring Inc
28 Apr 17
Annual report (foreign)
12:00am
and any future product candidates. None of our product candidates has been approved for marketing in China, the United States, the European Union or any … , the European Union or any other country, and we may never have marketable drugs. Our business is substantially dependent on our ability to complete
6-K
EX-1.1
ygc0nwyko83p
19 Jul 19
Current report (foreign)
4:02pm
6-K
EX-1.1
e7w3gg6 ua
22 May 19
Current report (foreign)
4:01pm
6-K
EX-1.1
e294j6f4 f8
29 Oct 19
Current report (foreign)
4:05pm
6-K
EX-1.1
amgahok
23 Jun 20
Current report (foreign)
4:09pm
6-K
EX-1.1
979hx t9yq
23 Nov 20
Current report (foreign)
4:16pm
424B5
7l5zl1fs0c0t9
19 Nov 20
Prospectus supplement for primary offering
4:12pm
424B5
15zez p2p4el
17 Nov 20
Prospectus supplement for primary offering
4:19pm
- Prev
- 1
- Next